🟢 Firefly Neuroscience is trading 13.97% up today after announcing strategic collaboration with Radial

Firefly Neuroscience is trading 13.97% up at $1.06 after announcing a strategic collaboration with Radial on September 17, 2026.

• The companies plan to integrate Firefly’s FDA 510(k)-cleared Evoke EEG/ERP platform with RadialOS, an AI-native operating system supporting brain-medicine clinics.
• The integration could expand clinical use of Firefly’s technology, although the announcement does not explicitly attribute the share-price move to the collaboration.
• The Nasdaq Composite is up 1.27%, reflecting broader risk-on sentiment.